TrialClinical drug investigation2006

Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study.

S Rasmussen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.